A recent press release from Fulcrum Therapeutics, a Massachusetts-based biotechnology company, announced preliminary findings of the company’s phase 1 clinical study of losmapimod in the treatment
According to a story from abc.net.au, Darren Bullock is getting pretty long in the tooth—at least for a cystic fibrosis patient. He is 44 years
Check out Part One here! Sean Baumstark and Kyle Bryant, hosts of the 2 Disabled Dudes Podcast, led a panel discussion with Neena Nizar, Onno
Sometimes, rare diseases are so rare that they are just as unique as the individual who has it. One child was suffering from a fatal
This week, many cities and regions across the country acknowledged Indigenous Peoples’ Day, a day to remember and honor the histories and cultures of Native
According to a story from BioSpace, a global collaborative called the Trajectory Analysis Project recently released a study that utilized the North Star Ambulatory Assessment
© Copyright Patient Worthy
